<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35225122</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1521-0464</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>29</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Drug delivery</Title>
          <ISOAbbreviation>Drug Deliv</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Delivery of germacrone (GER) using macrophages-targeted polymeric nanoparticles and its application in rheumatoid arthritis.</ArticleTitle>
        <Pagination>
          <StartPage>692</StartPage>
          <EndPage>701</EndPage>
          <MedlinePgn>692-701</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/10717544.2022.2044936</ELocationID>
        <Abstract>
          <AbstractText>Macrophages can transform into M1 (pro-inflammatory) and M2 (anti-inflammatory) phenotypes, which mediate the immune/inflammatory response in rheumatoid arthritis (RA). Activated M1 phenotype macrophages and overexpression of folate (FA) receptors are abundant in inflammatory synovium and joints and promote the progression of RA. Germacrone (GER) can regulate the T helper 1 cell (Th1)/the T helper 2 cell (Th2) balance to delay the progression of arthritis. To deliver GER to inflammatory tissue cells to reverse M1-type proinflammatory cells and reduce inflammation, FA receptor-targeting nanocarriers loaded with GER were developed. In activated macrophages, FA-NPs/DiD showed significantly higher uptake efficiency than NPs/DiD. <i>In vitro</i> experiments confirmed that FA-NPs/GER could promote the transformation of M1 macrophages into M2 macrophages. In adjuvant-induced arthritis (AIA) rats, the biodistribution profiles showed selective accumulation at the inflammatory site of FA-NPs/GER, and significantly reduced the swelling and inflammation infiltration of the rat's foot. The levels of pro-inflammatory cytokines (TNF-α, IL-1β) in the rat's inflammatory tissue were significantly lower than other treatment groups, which indicated a significant therapeutic effect in AIA rats. Taken together, macrophage-targeting nanocarriers loaded with GER are a safe and effective method for the treatment of RA.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tan</LastName>
            <ForeName>Tingfei</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine, Hefei, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Qi</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chu</LastName>
            <ForeName>Weiwei</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine, Hefei, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Bo</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine, Hefei, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Jingjing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xia</LastName>
            <ForeName>Quan</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine, Hefei, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cao</LastName>
            <ForeName>Xi</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine, Hefei, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Drug Deliv</MedlineTA>
        <NlmUniqueID>9417471</NlmUniqueID>
        <ISSNLinking>1071-7544</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D045788">Sesquiterpenes, Germacrane</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>6902-91-6</RegistryNumber>
          <NameOfSubstance UI="C048393">germacrone</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053758" MajorTopicYN="Y">Nanoparticles</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045788" MajorTopicYN="N">Sesquiterpenes, Germacrane</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014018" MajorTopicYN="N">Tissue Distribution</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Germacrone</Keyword>
        <Keyword MajorTopicYN="N">macrophage polarization</Keyword>
        <Keyword MajorTopicYN="N">macrophage-targeted</Keyword>
        <Keyword MajorTopicYN="N">nanoparticles</Keyword>
        <Keyword MajorTopicYN="N">rheumatoid arthritis</Keyword>
      </KeywordList>
      <CoiStatement>The author declares no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>28</Day>
          <Hour>8</Hour>
          <Minute>55</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35225122</ArticleId>
        <ArticleId IdType="pmc">PMC8890522</ArticleId>
        <ArticleId IdType="doi">10.1080/10717544.2022.2044936</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Abbasi M, Mousavi MJ, Jamalzehi S, et al.  (2019). Strategies toward rheumatoid arthritis therapy; the old and the new. J Cell Physiol
234:10018–31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30536757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aggarwal BB, Yuan W, Li S, et al.  (2013). Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: identification of novel components of turmeric. Mol Nutr Food Res
57:1529–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23847105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>An JF, Sun Y, Zhang QL, et al.  (2014). The effects of germacrone on lipopolysaccharide-induced acute lung injury in neonatal rats. Cell Mol Biol
60:8–12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25399081</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bilthariya U, Jain N, Rajoriya V, et al.  (2015). Folate-conjugated albumin nanoparticles for rheumatoid arthritis-targeted delivery of etoricoxib. Drug Dev Ind Pharm
41:95–104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24164469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bosch X. (2011). Dendrimers to treat rheumatoid arthritis. ACS Nano
5:6779–85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21879710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chandrupatla D, Molthoff CFM, Lammertsma AA, et al.  (2019). The folate receptor β as a macrophage-mediated imaging and therapeutic target in rheumatoid arthritis . Drug Deliv Transl Res
9:366–78.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6328514</ArticleId>
            <ArticleId IdType="pubmed">30280318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen ML, Daddy JCKA, Xiao YY, et al.  (2017). Advanced nanomedicine for rheumatoid arthritis treatment: focus on active targeting. Expert Opin Drug Deliv
14:1141–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28847165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crielaard BJ, Rijcken CJ, Quan L, et al.  (2012). Glucocorticoid-loaded core-cross-linked polymeric micelles with tailorable release kinetics for targeted therapy of rheumatoid arthritis. Angew Chem Int Ed Engl
51:7254–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3499037</ArticleId>
            <ArticleId IdType="pubmed">22692876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dixon WG, Hyrich KL, Watson KD, et al.  (2010). Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR). Ann Rheum Dis
69:522–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2927681</ArticleId>
            <ArticleId IdType="pubmed">19854715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dolati S, Sadreddini S, Rostamzadeh D, et al.  (2016). Utilization of nanoparticle technology in rheumatoid arthritis treatment. Biomed Pharmacother
80:30–41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27133037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrari M, Onuoha SC, Pitzalis C. (2015). Trojan horses and guided missiles: targeted therapies in the war on arthritis. Nat Rev Rheumatol
11:328–37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25734971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gouveia VM, Lima SAC, Nunes C, et al.  (2015). Non-biologic nanodelivery therapies for rheumatoid arthritis. J Biomed Nanotechnol
11:1701–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26502635</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hofkens W, Grevers LC, Walgreen B, et al.  (2011). Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis. J Control Release
152:363–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21396411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu J-J, Cheng Y-J, Zhang X-Z. (2018). Recent advances in nanomaterials for enhanced photothermal therapy of tumors. Nanoscale
10:22657–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30500042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu X, Sun A, Kang W, et al.  (2017). Strategies and knowledge gaps for improving nanomaterial biocompatibility. Environ Int
102:177–89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28318601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jahangirian H, Lemraski EG, Webster TJ, et al.  (2017). A review of drug delivery systems based on nanotechnology and green chemistry: green nanomedicine. Int J Nanomedicine
12:2957–78.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5396976</ArticleId>
            <ArticleId IdType="pubmed">28442906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain S, Tran TH, Amiji M. (2015). Macrophage repolarization with targeted alginate nanoparticles containing IL-10 plasmid DNA for the treatment of experimental arthritis. Biomaterials
61:162–77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4464978</ArticleId>
            <ArticleId IdType="pubmed">26004232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jang SE, Hyam SR, Han MJ, et al.  (2013). Lactobacillus brevis G-101 ameliorates colitis in mice by inhibiting NF-κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages. J Appl Microbiol
115:888–96.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23742179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin K, Luo Z, Zhang B, et al.  (2018). Biomimetic nanoparticles for inflammation targeting. Acta Pharm Sin B
8:23–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5985691</ArticleId>
            <ArticleId IdType="pubmed">29872620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kinne RW, Brauer R, Stuhlmuller B, et al.  (2000). Macrophages in rheumatoid arthritis. Arthritis Res
2:189–202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC130001</ArticleId>
            <ArticleId IdType="pubmed">11094428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lawrence T, Natoli G. (2011). Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol
11:750–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22025054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y, Wo JM, Liu Q, et al.  (2009). Chemoprotective effects of Curcuma aromatica on esophageal carcinogenesis. Ann Surg Oncol
16:515–23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19018598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang H, Peng B, Dong C, et al.  (2018). Cationic nanoparticle as an inhibitor of cell-free DNA-induced inflammation. Nat Commun
9:4291–304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6191420</ArticleId>
            <ArticleId IdType="pubmed">30327464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim MS, Choung SY, Jeong KW. (2016). Germacrone inhibits estrogen receptor α-mediated transcription in MCF-7 breast cancer cells. Phytother Res
30:2036–43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27573551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y, Wang W, Fang B, et al.  (2013). Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis. Eur J Pharmacol
698:95–102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23117090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu W, Zhou Z, Naqvi SMAS, et al.  (2018). Meta-analysis on efficacy and safety of modified Guizhi Shaoyao Zhimu Tang with the western medicines in treating rheumatoid arthritis. Yangtze Med
2:161–70.</Citation>
        </Reference>
        <Reference>
          <Citation>Makabe H, Maru N, Kuwabara A, et al.  (2006). Anti-inflammatory sesquiterpenes from Curcuma zedoaria. Nat Prod Res
20:680–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16901812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McInnes IB, Schett G. (2017). Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet
389:2328–37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28612747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mehta M, Dureja H, Garg M. (2016). Development and optimization of boswellic acid-loaded proniosomal gel. Drug Deliv
23:3072–81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26953869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nikalje AP. (2015). Nanotechnology and its applications in medicine. Med Chem
5:81–9.</Citation>
        </Reference>
        <Reference>
          <Citation>Nogueira E, Gomes AC, Preto A, et al.  (2016). Folate-targeted nanoparticles for rheumatoid arthritis therapy. Nanomedicine
12:1113–26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26733257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ochoa CD, Stevens T. (2012). Studies on the cell biology of interendothelial cell gaps. Am J Physiol Lung Cell Mol Physiol
302:L275–L86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3289273</ArticleId>
            <ArticleId IdType="pubmed">21964402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rajeshkumar S, Menon S, Venkat Kumar S, et al.  (2019). Antibacterial and antioxidant potential of biosynthesized copper nanoparticles mediated through Cissus arnotiana plant extract. J Photochem Photobiol B
197:111531.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31212244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodrigo G, Almanza GR, Cheng Y, et al.  (2010). Antiproliferative effects of curcuphenol, a sesquiterpene phenol. Fitoterapia
81:762–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20385210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sahoo SK, Misra R, Parveen S. (2017). Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomed Cancer
8:73–124.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21703993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh H, Satija S, Kaur H, et al.  (2019). Novel drug delivery approaches for guggul. Plant Arch
19:983–93.</Citation>
        </Reference>
        <Reference>
          <Citation>Smolen JS, Landewé R, Breedveld FC, et al.  (2010). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis
69:964–75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2935329</ArticleId>
            <ArticleId IdType="pubmed">20444750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun X, Dong S, Li X, et al.  (2019). Delivery of siRNA using folate receptor-targeted pH-sensitive polymeric nanoparticles for rheumatoid arthritis therapy. Nanomedicine
20:102017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31128293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Udalova IA, Mantovani A, Feldmann M. (2016). Macrophage heterogeneity in the context of rheumatoid arthritis. Nat Rev Rheumatol
12:472–85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27383913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vezmar S, Becker A, Bode U, et al.  (2003). Biochemical and clinical aspects of methotrexate neurotoxicity. Chemotherapy
49:92–104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12714818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wadhwa R, Pandey P, Gupta G, et al.  (2019). Emerging complexity and the need for advanced drug delivery in targeting Candida species. Curr Top Med Chem
19:2593–609.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31746290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Q, Jiang H, Li Y, et al.  (2017). Targeting NF-kB signaling with polymeric hybrid micelles that co-deliver siRNA and dexamethasone for arthritis therapy. Biomaterials
122:10–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28107661</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Q, Jiang J, Chen W, et al.  (2016). Targeted delivery of low-dose dexamethasone using PCL–PEG micelles for effective treatment of rheumatoid arthritis. J Control Release
230:64–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27057749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, Zhuo F, Chu P, et al.  (2019). Germacrone alleviates collagen-induced arthritis via regulating Th1/Th2 balance and NF-κB activation. Biochem Biophys Res Commun
518:560–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31451221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu H, Liu Y, Zu S, et al.  (2016). In vitro antiviral effect of germacrone on feline calicivirus. Arch Virol
161:1559–67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7087046</ArticleId>
            <ArticleId IdType="pubmed">26997613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xia ZB, Yuan YJ, Zhang QH, et al.  (2018). Salvianolic acid B suppresses inflammatory mediator levels by downregulating NF-kappaB in a rat model of rheumatoid arthritis. Med Sci Monit
24:2524–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5939601</ArticleId>
            <ArticleId IdType="pubmed">29691361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang FQ, Li SP, Chen Y, et al.  (2005). Identification and quantitation of eleven sesquiterpenes in three species of Curcuma rhizomes by pressurized liquid extraction and gas chromatography–mass spectrometry. J Pharm Biomed Anal
39:552–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15946818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang FQ, Wang YT, Li SP. (2006). Simultaneous determination of 11 characteristic components in three species of Curcuma rhizomes using pressurized liquid extraction and high-performance liquid chromatography. J Chromatogr A
1134:226–31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17018231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang M, Feng X, Ding J, et al.  (2017). Nanotherapeutics relieve rheumatoid arthritis. J Control Release
252:108–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28257989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yya B, Lg A, Zhe WA, et al.  (2020). Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and re-polarization. Biomaterials
264:120390.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32980634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Q, Dehaini D, Zhang Y, et al.  (2018). Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis. Nat Nanotechnol
13:1182–90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30177807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao J, Zhao M, Yu C, et al.  (2017). Multifunctional folate receptor-targeting and PH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis. Int J Nanomedicine
12:6735–46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5600269</ArticleId>
            <ArticleId IdType="pubmed">28932117</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35225122</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1521-0464</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>29</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Drug delivery</Title>
          <ISOAbbreviation>Drug Deliv</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Delivery of germacrone (GER) using macrophages-targeted polymeric nanoparticles and its application in rheumatoid arthritis.</ArticleTitle>
        <Pagination>
          <StartPage>692</StartPage>
          <EndPage>701</EndPage>
          <MedlinePgn>692-701</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/10717544.2022.2044936</ELocationID>
        <Abstract>
          <AbstractText>Macrophages can transform into M1 (pro-inflammatory) and M2 (anti-inflammatory) phenotypes, which mediate the immune/inflammatory response in rheumatoid arthritis (RA). Activated M1 phenotype macrophages and overexpression of folate (FA) receptors are abundant in inflammatory synovium and joints and promote the progression of RA. Germacrone (GER) can regulate the T helper 1 cell (Th1)/the T helper 2 cell (Th2) balance to delay the progression of arthritis. To deliver GER to inflammatory tissue cells to reverse M1-type proinflammatory cells and reduce inflammation, FA receptor-targeting nanocarriers loaded with GER were developed. In activated macrophages, FA-NPs/DiD showed significantly higher uptake efficiency than NPs/DiD. <i>In vitro</i> experiments confirmed that FA-NPs/GER could promote the transformation of M1 macrophages into M2 macrophages. In adjuvant-induced arthritis (AIA) rats, the biodistribution profiles showed selective accumulation at the inflammatory site of FA-NPs/GER, and significantly reduced the swelling and inflammation infiltration of the rat's foot. The levels of pro-inflammatory cytokines (TNF-α, IL-1β) in the rat's inflammatory tissue were significantly lower than other treatment groups, which indicated a significant therapeutic effect in AIA rats. Taken together, macrophage-targeting nanocarriers loaded with GER are a safe and effective method for the treatment of RA.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tan</LastName>
            <ForeName>Tingfei</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine, Hefei, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Qi</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chu</LastName>
            <ForeName>Weiwei</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine, Hefei, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Bo</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine, Hefei, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Jingjing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xia</LastName>
            <ForeName>Quan</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine, Hefei, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cao</LastName>
            <ForeName>Xi</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine, Hefei, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Drug Deliv</MedlineTA>
        <NlmUniqueID>9417471</NlmUniqueID>
        <ISSNLinking>1071-7544</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D045788">Sesquiterpenes, Germacrane</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>6902-91-6</RegistryNumber>
          <NameOfSubstance UI="C048393">germacrone</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053758" MajorTopicYN="Y">Nanoparticles</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045788" MajorTopicYN="N">Sesquiterpenes, Germacrane</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014018" MajorTopicYN="N">Tissue Distribution</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Germacrone</Keyword>
        <Keyword MajorTopicYN="N">macrophage polarization</Keyword>
        <Keyword MajorTopicYN="N">macrophage-targeted</Keyword>
        <Keyword MajorTopicYN="N">nanoparticles</Keyword>
        <Keyword MajorTopicYN="N">rheumatoid arthritis</Keyword>
      </KeywordList>
      <CoiStatement>The author declares no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>28</Day>
          <Hour>8</Hour>
          <Minute>55</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35225122</ArticleId>
        <ArticleId IdType="pmc">PMC8890522</ArticleId>
        <ArticleId IdType="doi">10.1080/10717544.2022.2044936</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Abbasi M, Mousavi MJ, Jamalzehi S, et al.  (2019). Strategies toward rheumatoid arthritis therapy; the old and the new. J Cell Physiol
234:10018–31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30536757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aggarwal BB, Yuan W, Li S, et al.  (2013). Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: identification of novel components of turmeric. Mol Nutr Food Res
57:1529–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23847105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>An JF, Sun Y, Zhang QL, et al.  (2014). The effects of germacrone on lipopolysaccharide-induced acute lung injury in neonatal rats. Cell Mol Biol
60:8–12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25399081</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bilthariya U, Jain N, Rajoriya V, et al.  (2015). Folate-conjugated albumin nanoparticles for rheumatoid arthritis-targeted delivery of etoricoxib. Drug Dev Ind Pharm
41:95–104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24164469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bosch X. (2011). Dendrimers to treat rheumatoid arthritis. ACS Nano
5:6779–85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21879710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chandrupatla D, Molthoff CFM, Lammertsma AA, et al.  (2019). The folate receptor β as a macrophage-mediated imaging and therapeutic target in rheumatoid arthritis . Drug Deliv Transl Res
9:366–78.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6328514</ArticleId>
            <ArticleId IdType="pubmed">30280318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen ML, Daddy JCKA, Xiao YY, et al.  (2017). Advanced nanomedicine for rheumatoid arthritis treatment: focus on active targeting. Expert Opin Drug Deliv
14:1141–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28847165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crielaard BJ, Rijcken CJ, Quan L, et al.  (2012). Glucocorticoid-loaded core-cross-linked polymeric micelles with tailorable release kinetics for targeted therapy of rheumatoid arthritis. Angew Chem Int Ed Engl
51:7254–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3499037</ArticleId>
            <ArticleId IdType="pubmed">22692876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dixon WG, Hyrich KL, Watson KD, et al.  (2010). Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR). Ann Rheum Dis
69:522–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2927681</ArticleId>
            <ArticleId IdType="pubmed">19854715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dolati S, Sadreddini S, Rostamzadeh D, et al.  (2016). Utilization of nanoparticle technology in rheumatoid arthritis treatment. Biomed Pharmacother
80:30–41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27133037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrari M, Onuoha SC, Pitzalis C. (2015). Trojan horses and guided missiles: targeted therapies in the war on arthritis. Nat Rev Rheumatol
11:328–37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25734971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gouveia VM, Lima SAC, Nunes C, et al.  (2015). Non-biologic nanodelivery therapies for rheumatoid arthritis. J Biomed Nanotechnol
11:1701–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26502635</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hofkens W, Grevers LC, Walgreen B, et al.  (2011). Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis. J Control Release
152:363–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21396411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu J-J, Cheng Y-J, Zhang X-Z. (2018). Recent advances in nanomaterials for enhanced photothermal therapy of tumors. Nanoscale
10:22657–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30500042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu X, Sun A, Kang W, et al.  (2017). Strategies and knowledge gaps for improving nanomaterial biocompatibility. Environ Int
102:177–89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28318601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jahangirian H, Lemraski EG, Webster TJ, et al.  (2017). A review of drug delivery systems based on nanotechnology and green chemistry: green nanomedicine. Int J Nanomedicine
12:2957–78.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5396976</ArticleId>
            <ArticleId IdType="pubmed">28442906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain S, Tran TH, Amiji M. (2015). Macrophage repolarization with targeted alginate nanoparticles containing IL-10 plasmid DNA for the treatment of experimental arthritis. Biomaterials
61:162–77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4464978</ArticleId>
            <ArticleId IdType="pubmed">26004232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jang SE, Hyam SR, Han MJ, et al.  (2013). Lactobacillus brevis G-101 ameliorates colitis in mice by inhibiting NF-κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages. J Appl Microbiol
115:888–96.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23742179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin K, Luo Z, Zhang B, et al.  (2018). Biomimetic nanoparticles for inflammation targeting. Acta Pharm Sin B
8:23–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5985691</ArticleId>
            <ArticleId IdType="pubmed">29872620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kinne RW, Brauer R, Stuhlmuller B, et al.  (2000). Macrophages in rheumatoid arthritis. Arthritis Res
2:189–202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC130001</ArticleId>
            <ArticleId IdType="pubmed">11094428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lawrence T, Natoli G. (2011). Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol
11:750–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22025054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y, Wo JM, Liu Q, et al.  (2009). Chemoprotective effects of Curcuma aromatica on esophageal carcinogenesis. Ann Surg Oncol
16:515–23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19018598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang H, Peng B, Dong C, et al.  (2018). Cationic nanoparticle as an inhibitor of cell-free DNA-induced inflammation. Nat Commun
9:4291–304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6191420</ArticleId>
            <ArticleId IdType="pubmed">30327464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim MS, Choung SY, Jeong KW. (2016). Germacrone inhibits estrogen receptor α-mediated transcription in MCF-7 breast cancer cells. Phytother Res
30:2036–43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27573551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y, Wang W, Fang B, et al.  (2013). Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis. Eur J Pharmacol
698:95–102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23117090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu W, Zhou Z, Naqvi SMAS, et al.  (2018). Meta-analysis on efficacy and safety of modified Guizhi Shaoyao Zhimu Tang with the western medicines in treating rheumatoid arthritis. Yangtze Med
2:161–70.</Citation>
        </Reference>
        <Reference>
          <Citation>Makabe H, Maru N, Kuwabara A, et al.  (2006). Anti-inflammatory sesquiterpenes from Curcuma zedoaria. Nat Prod Res
20:680–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16901812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McInnes IB, Schett G. (2017). Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet
389:2328–37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28612747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mehta M, Dureja H, Garg M. (2016). Development and optimization of boswellic acid-loaded proniosomal gel. Drug Deliv
23:3072–81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26953869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nikalje AP. (2015). Nanotechnology and its applications in medicine. Med Chem
5:81–9.</Citation>
        </Reference>
        <Reference>
          <Citation>Nogueira E, Gomes AC, Preto A, et al.  (2016). Folate-targeted nanoparticles for rheumatoid arthritis therapy. Nanomedicine
12:1113–26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26733257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ochoa CD, Stevens T. (2012). Studies on the cell biology of interendothelial cell gaps. Am J Physiol Lung Cell Mol Physiol
302:L275–L86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3289273</ArticleId>
            <ArticleId IdType="pubmed">21964402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rajeshkumar S, Menon S, Venkat Kumar S, et al.  (2019). Antibacterial and antioxidant potential of biosynthesized copper nanoparticles mediated through Cissus arnotiana plant extract. J Photochem Photobiol B
197:111531.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31212244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodrigo G, Almanza GR, Cheng Y, et al.  (2010). Antiproliferative effects of curcuphenol, a sesquiterpene phenol. Fitoterapia
81:762–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20385210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sahoo SK, Misra R, Parveen S. (2017). Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomed Cancer
8:73–124.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21703993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh H, Satija S, Kaur H, et al.  (2019). Novel drug delivery approaches for guggul. Plant Arch
19:983–93.</Citation>
        </Reference>
        <Reference>
          <Citation>Smolen JS, Landewé R, Breedveld FC, et al.  (2010). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis
69:964–75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2935329</ArticleId>
            <ArticleId IdType="pubmed">20444750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun X, Dong S, Li X, et al.  (2019). Delivery of siRNA using folate receptor-targeted pH-sensitive polymeric nanoparticles for rheumatoid arthritis therapy. Nanomedicine
20:102017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31128293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Udalova IA, Mantovani A, Feldmann M. (2016). Macrophage heterogeneity in the context of rheumatoid arthritis. Nat Rev Rheumatol
12:472–85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27383913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vezmar S, Becker A, Bode U, et al.  (2003). Biochemical and clinical aspects of methotrexate neurotoxicity. Chemotherapy
49:92–104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12714818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wadhwa R, Pandey P, Gupta G, et al.  (2019). Emerging complexity and the need for advanced drug delivery in targeting Candida species. Curr Top Med Chem
19:2593–609.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31746290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Q, Jiang H, Li Y, et al.  (2017). Targeting NF-kB signaling with polymeric hybrid micelles that co-deliver siRNA and dexamethasone for arthritis therapy. Biomaterials
122:10–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28107661</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Q, Jiang J, Chen W, et al.  (2016). Targeted delivery of low-dose dexamethasone using PCL–PEG micelles for effective treatment of rheumatoid arthritis. J Control Release
230:64–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27057749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, Zhuo F, Chu P, et al.  (2019). Germacrone alleviates collagen-induced arthritis via regulating Th1/Th2 balance and NF-κB activation. Biochem Biophys Res Commun
518:560–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31451221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu H, Liu Y, Zu S, et al.  (2016). In vitro antiviral effect of germacrone on feline calicivirus. Arch Virol
161:1559–67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7087046</ArticleId>
            <ArticleId IdType="pubmed">26997613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xia ZB, Yuan YJ, Zhang QH, et al.  (2018). Salvianolic acid B suppresses inflammatory mediator levels by downregulating NF-kappaB in a rat model of rheumatoid arthritis. Med Sci Monit
24:2524–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5939601</ArticleId>
            <ArticleId IdType="pubmed">29691361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang FQ, Li SP, Chen Y, et al.  (2005). Identification and quantitation of eleven sesquiterpenes in three species of Curcuma rhizomes by pressurized liquid extraction and gas chromatography–mass spectrometry. J Pharm Biomed Anal
39:552–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15946818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang FQ, Wang YT, Li SP. (2006). Simultaneous determination of 11 characteristic components in three species of Curcuma rhizomes using pressurized liquid extraction and high-performance liquid chromatography. J Chromatogr A
1134:226–31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17018231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang M, Feng X, Ding J, et al.  (2017). Nanotherapeutics relieve rheumatoid arthritis. J Control Release
252:108–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28257989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yya B, Lg A, Zhe WA, et al.  (2020). Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and re-polarization. Biomaterials
264:120390.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32980634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Q, Dehaini D, Zhang Y, et al.  (2018). Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis. Nat Nanotechnol
13:1182–90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30177807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao J, Zhao M, Yu C, et al.  (2017). Multifunctional folate receptor-targeting and PH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis. Int J Nanomedicine
12:6735–46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5600269</ArticleId>
            <ArticleId IdType="pubmed">28932117</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
